All stock lists
Option Care Health, Inc. (NASDAQ:OPCH)
US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
$31.65+$0.15 (+0.48%)
Market cap
$4.74B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 15, 1996
Website
Insider Score
––Not scored
OPCH Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
OPCH analyst forecast
OPCH analyst consensus
Hold6 ratings
Buy 0 Hold 6 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
OPCH 12-month price target
No published price targets in the last 12 months.
Best analysts covering OPCH
- Citizens100%success rate · +22.3% avg return · 1 call
- Deutsche Bank100%success rate · +6.5% avg return · 1 call
- Barrington Research39%success rate · -3.2% avg return · 18 calls
- JP Morgan33%success rate · +0.8% avg return · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
OPCH analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | UBS | Neutral | — | — | Downgraded | 2026-10-09 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-10-07 |
| — | Citizens | Market Perform | — | — | Downgraded | 2026-10-07 |
| — | Jefferies | Hold | — | — | Downgraded | 2026-10-07 |
| — | Barrington Research | Market Perform | — | — | Downgraded | 2026-10-07 |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-10-07 |
| — | Deutsche Bank | Hold | — | — | Downgraded | 2026-07-30 |
| — | Stephens & Co. | Equal Weight | — | — | Downgraded | 2026-07-17 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-06-08 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-05-06 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-04 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-05-01 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-05-01 |
| — | UBS | Buy | — | — | Reiterated | 2026-05-01 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2026-01-16 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-01-13 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-01-13 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2025-12-09 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-12-09 |
| — | TD Cowen | Hold | — | — | Reiterated | 2025-11-03 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-10-31 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-10-31 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-09-23 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-07-31 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-07-10 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-06-18 |
| — | UBS | Buy | — | — | Upgraded | 2025-04-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-04-30 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-04-22 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-04-21 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-03-06 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-02-27 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-01-24 |
| — | Jefferies | Buy | — | — | Upgraded | 2025-01-23 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2025-01-14 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-01-10 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2024-11-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-11-01 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-10-31 |
| — | Jefferies | Hold | — | — | Downgraded | 2024-10-31 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-10-23 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-09-30 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-08-01 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-07-25 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-04-24 |
| — | Jefferies | Buy | — | — | Reiterated | 2024-03-04 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2024-02-23 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-10-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-10-18 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-07-28 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-06-27 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2023-05-05 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2023-05-05 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2022-10-28 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2022-08-22 |
| — | Barrington Research | Outperform | — | — | Reiterated | 2022-07-28 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2021-08-04 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2021-07-19 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2021-03-12 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2021-01-22 |
OPCH earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-24 | $0.46 | $0.46 | $1.46B | $1.47B |
| 2026-04-30 | $0.37 | $0.40 | $1.39B | $1.35B |
| 2026-07-29 | $0.43 | $0.45 | $1.42B | $1.44B |
| 2026-11-04 | $0.49 | $0.49 | $1.48B | $1.49B |
| 2027-02-23Upcoming | $0.54 | — | $1.49B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.